![imagen por defecto](https://www.csic.es/sites/www.csic.es/files/styles/imagen_370x350/public/default_images/investigador-default_1.png?itok=lu0xonwO)
EVA MARIA GALVEZ BUERBA
Instituto
- TREATMENT OF FUNGAL INFECTIONS OR DISEASES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USO DE SSDIMETILGLIOTOXINA COMO MARCADOR DIAGNOSTICO DE PATOLOGIAS CAUSADAS POR HONGOS PRODUCTORES DE GLIOTOXINA O DE SUS DERIVADOS
- TREATMENT OF FUNGAL INFECTIONS OR DISEASES